Alzheimer’s expert reveals how to reduce dementia risk — when to eat breakfast, what goes in coffee
I’ve tried everything,” Dr. Nathaniel Chin, an associate professor at the University of Wisconsin Department of Medicine, ...
Mountain climbing and treating Alzheimer's: Could xenon gas have potential?
In a trial featuring a mouse model of Alzheimer's, scientists found that inhaling a mixture containing xenon gas helped ...
STAT3d
Could inhaling xenon gas help treat Alzheimer’s? A new mouse study suggests it might
The gas xenon, like the other noble, or inert, gases, is known for doing very little. The class of elements, because of its ...
‘Novel approach’ to treating Alzheimer’s disease discovered — it’s a gas
Alzheimer’s is the most common form of dementia — it causes memory loss, confusion, thinking problems and behavioral changes.
Sundown Syndrome Is Why People With Alzheimer's Get More Confused at Night
Brain damage caused by dementia can lead to anxiety, fear, and irritability, especially in the evening. This is how ...
Woman claims Alzheimer’s symptoms were reversed after five years
In “The Last Alzheimer’s Patient,” CNN chief medical correspondent follows Alzheimer’s patient Cici Zerbe who says her ...
Science Daily12h
Florescent probes illuminate cholesterol and Alzheimer's research
Cutting-edge fluorescent cholesterol probes now enable scientists to visualize cholesterol movement and distribution in live cells with unprecedented detail. By combining computer simulations with ...
Why Do Taxi Drivers Have a Lower Risk of Alzheimer’s?
The finding has implications for all of us, write Harvard physician-researchers Christopher Worsham and Anupam Jena.
ConsumerAffairs1d
New study suggests ultrasound might be a promising treatment for Alzheimer’s disease
Researchers report hopeful progress in efforts to find treatments for Alzheimer’s disease. They report a recent clinical ...
FiercePharma1d
Analysts tip Eisai, Biogen and Lilly to drive eightfold explosion in Alzheimer's market value
GlobalData analysts are predicting an Alzheimer’s disease market boom, tipping its value across major regions to increase ...
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the ...
Dartmouth Health hopes to improve Alzheimer's care with new program
Dartmouth Health is the only health care system on the East Coast to be part of the newly launched Brain Health Navigator ...